{"transactions":[{"id":3688161,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":160901,"kind":"person","name":"McVeigh Brian","position":1,"cik":"0001742110","reported_name":"McVeigh Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-24T20:25:34.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on January 22, 2020, and the remainder vests in equal monthly installments thereafter over 36 months."}],"balance_after":125000,"derivative":{"exercise_price":4.63,"expiration_date":"2029-01-22","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-19-001928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742110/000089924319001928/doc4.xml","form_type":"4"}},{"id":3914258,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":160901,"kind":"person","name":"McVeigh Brian","position":1,"cik":"0001742110","reported_name":"McVeigh Brian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-30T17:32:42.000Z","date":"2018-05-29","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on May 29, 2019 and the remainder vests in equal monthly installments thereafter over a 3-year period. The option has been granted pursuant to an inducement award agreement outside of the company's 2014 Stock Option and Incentive Plan as a material inducement to the reporting person's acceptance of employment with the company in accordance with NASDAQ Listing Rule 5635(c)(4). The option is subject to acceleration upon a change in control pursuant to the terms of the reporting person's Severance and Change in Control Agreement dated as of May 29, 2018."}],"balance_after":225000,"derivative":{"exercise_price":6.46,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0000899243-18-014478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742110/000089924318014478/doc4.xml","form_type":"4"}}]}